Citigroup
AHCO icon

Citigroup’s AdaptHealth AHCO Stock Holding History

Citigroup’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-333,300
Closed -$6.01M – 5786
2022
Q2 		$6.01M Buy
+333,300
New +$5.41M ﹤0.01% 1429

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup's AHCO Position: Q1 2026 in Review

Citigroup increased its AdaptHealth (AHCO) stake by 109% in Q1 2026, buying an estimated $522K and bringing the position to 97,738 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3018.

Citigroup first reported a position in AHCO in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.73M in Q1 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Citigroup held 97,738 shares of AdaptHealth worth $1.16M as of Q1 2026.
  • Citigroup bought 50,971 AdaptHealth shares in Q1 2026, an estimated $522K.
  • AdaptHealth made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3018 holding.
  • Citigroup first reported a position in AdaptHealth in Q4 2019 and has held it in 26 quarters since.
  • Citigroup's AdaptHealth position peaked at $1.73M in Q1 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.